PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.66%
Revenue growth at 50-75% of MCHP's 11.37%. Martin Whitman would worry about competitiveness or product relevance.
6.29%
Gross profit growth under 50% of MCHP's 14.85%. Michael Burry would be concerned about a severe competitive disadvantage.
8.23%
Positive EBIT growth while MCHP is negative. John Neff might see a substantial edge in operational management.
8.57%
Operating income growth under 50% of MCHP's 63.74%. Michael Burry would be concerned about deeper cost or sales issues.
0.46%
Net income growth under 50% of MCHP's 19.88%. Michael Burry would suspect the firm is falling well behind a key competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-0.72%
Share reduction while MCHP is at 0.26%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-1.11%
Reduced diluted shares while MCHP is at 1.46%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
0.73%
Dividend growth above 1.5x MCHP's 0.02%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
-29.07%
Negative OCF growth while MCHP is at 161.01%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-13.10%
Negative FCF growth while MCHP is at 231.91%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
53.66%
10Y revenue/share CAGR at 75-90% of MCHP's 64.83%. Bill Ackman would press for new markets or product lines to narrow the gap.
48.77%
5Y revenue/share CAGR above 1.5x MCHP's 2.50%. David Dodd would look for consistent product or market expansions fueling outperformance.
17.46%
Positive 3Y CAGR while MCHP is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
133.79%
10Y OCF/share CAGR at 75-90% of MCHP's 166.48%. Bill Ackman would demand strategic changes to close the gap in long-term cash generation.
87.28%
5Y OCF/share CAGR above 1.5x MCHP's 24.50%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
49.88%
3Y OCF/share CAGR above 1.5x MCHP's 3.83%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
106.89%
Net income/share CAGR above 1.5x MCHP's 24.67% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
120.86%
Positive 5Y CAGR while MCHP is negative. John Neff might view this as a strong mid-term relative advantage.
49.13%
Positive short-term CAGR while MCHP is negative. John Neff would see a clear advantage in near-term profit trajectory.
15.89%
Below 50% of MCHP's 245.53%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
13.63%
5Y equity/share CAGR at 50-75% of MCHP's 21.55%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
1.63%
Positive short-term equity growth while MCHP is negative. John Neff sees a strong advantage in near-term net worth buildup.
463.52%
Dividend/share CAGR of 463.52% while MCHP is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
378.03%
5Y dividend/share CAGR at 50-75% of MCHP's 747.72%. Martin Whitman might see a lagging policy in mid-term shareholder returns.
200.44%
3Y dividend/share CAGR above 1.5x MCHP's 57.63%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
19.50%
AR growth well above MCHP's 10.75%. Michael Burry fears inflated revenue or higher default risk in the near future.
6.16%
We show growth while MCHP is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
2.07%
Positive asset growth while MCHP is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
1.59%
Under 50% of MCHP's 46.70%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
No Data
No Data available this quarter, please select a different quarter.
4.52%
R&D growth drastically higher vs. MCHP's 7.72%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
3.16%
SG&A declining or stable vs. MCHP's 9.14%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.